Target intelligence / Profile preview

Volume-regulated anion channel subunit LRRC8C (LRRC8C)

Target
LRRC8C
Molecular classification
Ion channel, Volume-regulated anion channel (VRAC) subunit, Leucine-rich repeat-containing protein
01

Overview

The **volume-regulated anion channel subunit LRRC8C** (LRRC8C) is a transmembrane protein that forms part of the VRAC complex, a hexameric ion channel responsible for mediating chloride and other anion currents across cell membranes in response to cell swelling[1][2][3]. VRAC complexes are heteromers comprising various combinations of LRRC8A-E subunits, with LRRC8A being obligatory for function and LRRC8C modulating channel properties and activation[2][3]. LRRC8C, by interacting with the core LRRC8A subunits, destabilizes their tightly closed conformation, facilitating activation of the VRAC under osmotic stress[1][2]. LRRC8C is highly expressed in the heart among other tissues[3]. Pathogenic variants in LRRC8C can drive aberrant channel activity, which is linked to abnormal cell volume regulation – an underlying factor in diseases such as cancer progression and brain ischemia[1]. To date, there are no highly selective pharmacological agents targeting LRRC8C individually, and research continues into its specific roles in human health and disease[3].

Other names
Factor for adipocyte differentiation 158FAD158AD158TimesLeucine-rich repeat-containing protein 8CLeucine rich repeat containing 8 family member Chypothetical protein AD158
02

Mechanism of action

Channel modulators (such as DCPIB) inhibit VRAC activity, altering cell volume regulation and potentially downstream processes like cell survival

03

Biological functions

Cell volume regulationIon transportCell survival under osmotic stressPotential roles in apoptosis and signal transduction
04

Disease associations

CancerIschemia-reperfusion injuryNeurological diseasemetabolic disorders (potential but less established)
05

Safety considerations

Broad channel inhibition may impair normal cell volume regulation, potentially impacting numerous tissues (e.g., cardiac, neural)
06

Interacting drugs

None specifically established; VRAC as a complex is affected by broad anion channel blockers like DCPIB, but no approved drugs are known to act selectively on LRRC8C subunit
07

Biomarkers

No well-established LRRC8C-specific biomarkers; VRAC activity assays may reflect function indirectly

Beyond the preview

Go deeper on Volume-regulated anion channel subunit LRRC8C (LRRC8C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Volume-regulated anion channel subunit LRRC8C (LRRC8C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call